※Photographing or reproducing slides, videos of presentations, and abstracts is strictly prohibited without prior permission from the presenter and/or the GBCC.
*Uploaded presentation materials and recording videos of presentation are under the copyright transfer agreement.
08:00-09:15
- GBCC-SSO Joint Session
-
- Venue: RM 3(Walker Hall 1)
- Clinical Trials of Breast Cancer Surgery in Korea & Introduction to KBCSG
- Han-Byoel Lee
- (Seoul National Univ. Hospital, Korea)
Slide ViewVideo ViewAbstract
- Trials in Breast Cancer Lead by Surgical Oncologists in the US & Introduction to SSO
- Jennifer Plichta
- (Duke Univ. Medical Center, U.S.A.)
Slide ViewVideo ViewAbstract
08:30-09:15
- Satellite Symposium 2:
- Novartis
- Venue: RM 1(Vista 1+2)
- The Evolving Landscape of HR+/HER2- Breast Cancer Treatment
- Aditya Bardia
- (Massachusetts General Hospital, U.S.A.)
Slide ViewVideo ViewAbstract
09:30-10:15
- Plenary Lecture 3
-
- Venue: RM 1(Vista 1+2)
- Defining Today’s Surgical Standards of Care in Patients with Breast Cancer
- Walter Paul Weber
- (Univ. Hospital Basel, Switzerland)
Slide ViewVideo ViewAbstract
10:30-11:45
- Symposium 3:
- Translational Approach through Cancer Genomics and Biology
- Venue: RM 1(Vista 1+2)
- Genomic Amplification Linked to Therapeutic Resistance in Breast Cancer
- Jeong-Yeon Lee
- (Hanyang Univ. College of Medicine, Korea)
Abstract
- Immune Biomarker and Ecosystem in Breast Cancer
- Alex Swarbrick
- (Garvan Institute of Medical Research, Australia)
Slide ViewVideo ViewAbstract
- Genomics Related to Treatment After CDK4/6 Inhibitors in Hormone Receptor Positive Breast Cancer
- Rinath Jeselsohn
- (Dana-Farber Cancer Institute, U.S.A.)
Slide ViewVideo ViewAbstract
- Panel Discussion 5:
- Obesity, Life Style Modification, and Exercise
- Venue: RM 2(Vista 3)
- The Role of Weight Loss and Metformin in the Adjuvant Treatment of Breast Cancer
- Pamela Goodwin
- (Lunenfeld Tanenbaum Research Institute at Sinai Health System, Univ. of Toronto, Canada)
Slide ViewVideo ViewAbstract
- Life Style Modification of Breast Cancer Survivors
- Hyun Jo Youn
- (Jeonbuk National Univ. Hospital, Korea)
Slide ViewVideo ViewAbstract
- Physical Activity Intervention in Women with Breast Cancer
- Justin Y. Jeon
- (Yonsei Cancer Center, Korea)
Slide ViewVideo ViewAbstract
- Education Session 5:
- Update in the Management of Adverse Events
- Venue: RM 3(Walker Hall 1)
- Management of Cardiotoxicity of Breast Cancer
- Woo-Baek Chung
- (Seoul St. Mary’s Hospital, Korea)
Slide ViewVideo ViewAbstract
- Management of AIMSS (Aromatase-inhibitor-associated Musculoskeletal Syndrome)
- Eun Joo Yang
- (Daerim St. Mary's Hospital, Korea)
Slide ViewVideo ViewAbstract
- Management of Chemotherapy Induced Nausea and Vomiting (CINV)
- Toshiaki Saeki
- (Saitama Medical Univ. International Medical Center, Japan)
Slide ViewVideo ViewAbstract
- Oral Presentation 3
-
- Venue: RM 4(Walker Hall 2)
- ABCN Business Meeting (Invited Only)
-
- Venue: RM 5(Art Hall)
- Legacy of GBCC: Beyond Asia Towards the World, New Era of GBCC
- Joon Jeong
- (Gangnam Severance Hospital, Korea)
- Sharing Wisdom, Sharing Strength - Mentorship and International Collaboration
- Philip Poortmans
- (Iridium Netwerk & Univ. of Antwerp, Belgium)
- Knowledge, Attitude, Practice Behaviors and Barriers for Fertility Preservation
- Heejeong Kim
- (ASAN Medical Center, Korea)
12:00-12:45
- Plenary Lecture 4
-
- Venue: RM 1(Vista 1+2)
- Optimising Radiation Therapy in Early Stage Breast Cancer
- Philip Poortmans
- (Iridium Netwerk & Univ. of Antwerp, Belgium)
Slide ViewVideo ViewAbstract
13:00-13:45
- Satellite Symposium 3:
- Roche Korea
- Venue: RM 1(Vista 1+2)
- Transforming the Treatment Journey for HER2+ Breast Cancer Patients
- Joyce O'Shaughnessy
- (Baylor Univ. Medical Center, U.S.A.)
Slide ViewVideo ViewAbstract
14:00-14:45
- Plenary Lecture 5
-
- Venue: RM 1(Vista 1+2)
- Presurgical Window Studies for Drug Development, Studies of Resistance and Patient Management
- Mitch Dowsett
- (Royal Marsden Hospital, UK)
Abstract
15:00-16:15
- Symposium 4:
- Immunotherapy in Breast Cancer
- Venue: RM 1(Vista 1+2)
- Current Status of Immunotherapy: Where are We?
- Hiroji Iwata
- (Aichi Cancer Center Hospital, Japan)
Slide ViewVideo ViewAbstract
- Biomarker for Immunotherapy: What is the Best?
- Peter Schmid
- (Bart's Cancer Institute, UK)
- Challenge for Immunotherapy in Breast Cancer: Hot or Cold
- Sherene Loi
- (Univ. of Melbourne, Australia)
Video View
- Panel Discussion 6:
- Updates of Combined Management for Metastatic Breast Cancer
- Venue: RM 2(Vista 3)
- Timing of Breast Surgery in Metastatic Breast Cancer: Is It Really Necessary to Perform Palliative Mastectomy?
- Sung Gwe Ahn
- (Gangnam Severance Hospital, Korea)
Slide ViewVideo ViewAbstract
- Current Status of Locoregional Therapy in ER+/HER2- Oligometastatic Breast Cancer
- Takayuki Ueno
- (The Cancer Institute Hospital of JFCR, Japan)
Slide ViewVideo ViewAbstract
- Role of Stereotactic Ablative Radiotherapy in Oligometastatic Breast Cancer
- Steven J. Chmura
- (Univ. of Chicago, U.S.A.)
Slide ViewVideo ViewAbstract
- Education Session 6:
- Psychologic Problem Management
- Venue: RM 3(Walker Hall 1)
- Oral Presentation 4
-
- Venue: RM 4(Walker Hall 2)
- Nursing Session 1 (Korean):
- Challenges of Nursing Care Beyond a Pandemic
- Venue: RM 5(Art Hall)
- The Education for Breast Cancer Patients During Covid Pandemic
- Jiyoung Choi
- (Seoul National Univ. Bundang Hospital, Korea)
Slide ViewAbstract
- Supportive Care Post Pandemic Breast Cancer Patients
- In Jeong Cho
- (Wonju Severance Christian Hospital, Korea)
Abstract
- Experience of Education for Breast Cancer Patients post COVID-19
- Nayeon Kim
- (Samsung Medical Center, Korea)
Slide ViewAbstract
16:30-17:45
- Symposium 5:
- Recent Updates for Surgery After Neoadjuvant Chemotherapy
- Venue: RM 1(Vista 1+2)
- De-escalation of Axillary Surgery After NACT
- Jeong Eon Lee
- (Samsung Medical Center, Korea)
Slide ViewVideo ViewAbstract
- De-escalation of Breast Surgery After NACT
- Peter C. Dubsky
- (Hirslanden Klinik St. Anna, Switzerland)
Slide ViewVideo ViewAbstract
- Can We Select Patients in Whom We Can Forego Any Axillary Treatment after up front Chemotherapy?
- Emiel Rutgers
- (Netherlands Cancer Institute, Netherlands)
Slide ViewVideo ViewAbstract
- Panel Discussion 7:
- How to Apply Multigene Panel for ER+ EBC- Asia vs. Western
- Venue: RM 2(Vista 3)
- Multigene Assays: What Evidence Do We Have?
- Janice Tsang
- (The Univ. of Hong Kong, Hong Kong)
Slide ViewVideo ViewAbstract
- Is There any Difference in Multigene Assays Developed from Asian and Western Countries?
- Han-Byoel Lee
- (Seoul National Univ. Hospital, Korea)
Slide ViewVideo ViewAbstract
- Practical Application of Multigene Assays in Real Clinical Setting (Asia vs. Western)
- Rebecca Dent
- (National Cancer Centre Singapore, Singapore)
Abstract
- Education Session 7:
- Tailored Adjuvant Endocrine Therapy in ER+ Breast Cancer
- Venue: RM 3(Walker Hall 1)
- Optimal Treatment Options for High Risk ER+ Breast Cancer
- Maria-Joao Cardoso
- (Champalimaud Foundation, Portugal)
Slide ViewVideo ViewAbstract
- Extended Endocrine Therapy, Optimal Duration and Sequence
- Sung Hoon Sim
- (National Cancer Center, Korea)
Slide ViewVideo ViewAbstract
- Ovarian Suppression with/without Adjuvant Chemotherapy in High-risk Premenopausal Patients
- Shin-Cheh Chen
- (Chang Gung Memorial Hospital, Taiwan)
Slide ViewVideo ViewAbstract
- Oral Presentation 5
-
- Venue: RM 4(Walker Hall 2)
- Nursing Session 2 (Korean):
- Return to Life Beyond Cure Among Young Women
- Venue: RM 5(Art Hall)
- Working Young Women with Breast Cancer: For a Life that Makes Me Who I Am
- Ka Ryeong Bae
- (National Cancer Center, Korea)
Slide ViewAbstract
- Human Flourishing in Adolescents and Young Adults with Cancer
- Eunji Cho
- (Vanderbilt Univ., Korea)
Slide ViewAbstract
- Fertility Preservation for Women with Breast Cancer
- Jeehee Han
- (Chung-Ang Univ. College of Nursing, Korea)
Slide ViewAbstract
18:00-18:45
- Satellite Symposium 4:
- Lilly Korea
- Venue: RM 1(Vista 1+2)
- Verzenio, Potent CDK4/6 Inhibitor, How to Optimize HR+/HER2- mBC Patient with CDK4/6 Inhibitors
- Tomoyuki Aruga
- (Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Japan)
Slide ViewVideo ViewAbstract